ArticleACR open rheumatology2026

Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes.

Arjun Mahajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.